当前位置:首页 - 行情中心 - 国药股份(600511) - 财务分析

国药股份

(600511)

  

流通市值:167.83亿  总市值:228.84亿
流通股本:5.53亿   总股本:7.55亿

国药股份(600511)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年年度实现净利润21.30亿元,每股收益2.65元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年年度最新股东权益1897504.33万元,未分配利润1339017.83万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年年度最新总资产3492827.92万元,负债1595323.60万元。

利润表
报告期2024-12-312024-09-302024-06-302024-03-31
营业总收入50,597,449,788.5738,028,539,709.4924,756,503,031.4712,122,142,562.33
营业总成本48,403,886,743.9336,311,068,962.0323,626,002,706.2511,584,004,995.37
营业利润2,677,421,914.451,989,261,474.351,329,608,744.97613,798,834.54
利润总额2,653,612,391.51,965,833,872.951,317,834,072.57613,536,476.75
净利润2,129,780,565.041,574,927,175.31,063,673,008.77495,118,467.38
其他综合收益-3,461,287.34-4,446,206.5-8,526,585.89-5,853,233.88
综合收益总额2,126,319,277.71,570,480,968.81,055,146,422.88489,265,233.5
资产负债表
报告期2024-12-312024-09-302024-06-302024-03-31
流动资产合计30,356,823,125.0829,770,544,832.5729,184,077,116.6428,551,197,141.66
非流动资产合计4,571,456,118.544,565,488,713.994,369,762,431.034,367,859,261.29
资产总计34,928,279,243.6234,336,033,546.5633,553,839,547.6732,919,056,402.95
流动负债合计14,855,742,064.9414,617,483,733.6414,361,158,061.7713,732,763,454.18
非流动负债合计1,097,493,887.661,262,200,416.651,250,794,276.051,165,249,540.75
负债合计15,953,235,952.615,879,684,150.2915,611,952,337.8214,898,012,994.93
归属于母公司股东权益合计17,128,090,785.5216,608,250,755.7216,123,409,266.5816,229,371,972.37
股东权益合计18,975,043,291.0218,456,349,396.2717,941,887,209.8518,021,043,408.02
负债和股东权益合计34,928,279,243.6234,336,033,546.5633,553,839,547.6732,919,056,402.95
现金流量表
报告期2024-12-312024-09-302024-06-302024-03-31
经营活动现金流入小计55,348,362,559.9939,559,819,298.3225,331,095,593.7811,831,696,271.95
经营活动现金流出小计53,689,243,036.1740,589,663,930.4126,397,073,937.8613,551,495,648.62
经营活动产生的现金流量净额1,659,119,523.82-1,029,844,632.09-1,065,978,344.08-1,719,799,376.67
投资活动现金流入小计47,062,295.4826,469,817.6121,833,482.5118,650,405.9
投资活动现金流出小计2,630,772,379.16167,968,899.67127,774,774.8920,980,082.45
投资活动产生的现金流量净额-2,583,710,083.68-141,499,082.06-105,941,292.38-2,329,676.55
筹资活动现金流入小计315,981,517.06283,109,437.63154,586,850.23338,197,804.88
筹资活动现金流出小计1,898,314,943.411,754,026,234.631,301,209,470.27221,616,224.26
筹资活动产生的现金流量净额-1,582,333,426.35-1,470,916,797-1,146,622,620.04116,581,580.62
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-2,506,923,986.21-2,642,260,511.15-2,318,542,256.5-1,605,547,472.6
期末现金及现金等价物余额8,291,394,056.968,156,057,532.028,479,775,786.679,192,770,570.57
最新报告期:2025-03-24
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
中信建投刘若飞,贺菊颖2.853.073.312025-03-24
中金公司夏璐,张琎,朱言音2.823.01--2025-03-24
华福证券何展聪,陈铁林2.853.043.252025-03-24
华泰证券代雯,孔垂岩,王殷杰2.782.923.072025-03-20
TOP↑